Ying-hua Liu

Guangzhou Municipal And Guangdong Provincial Key Laboratory Of Molecular Target & Clinical Pharmacology
Guangzhou, 511436, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Zonisamide improves cognitive impairment and psychiatric symptoms related with SAPAP3 in mouse models of Alzheimer's disease.

Zonisamide improves cognitive impairment and psychiatric symptoms related with SAPAP3 in mouse models of Alzheimer's disease.

Journal: European journal of pharmacology

Published: March 04, 2026

Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition.

Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition.

Journal: Acta pharmacologica Sinica

Published: July 09, 2023

A novel onco-cardiological mouse model of lung cancer-induced cardiac dysfunction and its application in identifying potential roles of tRNA-derived small RNAs.

A novel onco-cardiological mouse model of lung cancer-induced cardiac dysfunction and its application in identifying potential roles of tRNA-derived small RNAs.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 20, 2023

Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity.

Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity.

Journal: Pharmacology

Published: May 26, 2022

Zonisamide alleviates cardiac hypertrophy in rats by increasing Hrd1 expression and inhibiting endoplasmic reticulum stress.

Zonisamide alleviates cardiac hypertrophy in rats by increasing Hrd1 expression and inhibiting endoplasmic reticulum stress.

Journal: Acta pharmacologica Sinica

Published: September 12, 2020

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus.

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus.

Journal: Frontiers in aging neuroscience

Published: April 28, 2020

Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress.

Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress.

Journal: Acta pharmacologica Sinica

Published: October 16, 2019

Increased expression of Sonic hedgehog restores diabetic endothelial progenitor cells and improves cardiac repair after acute myocardial infarction in diabetic mice.

Increased expression of Sonic hedgehog restores diabetic endothelial progenitor cells and improves cardiac repair after acute myocardial infarction in diabetic mice.

Journal: International journal of molecular medicine

Published: February 16, 2019

Minocycline protects against myocardial ischemia/reperfusion injury in rats by upregulating MCPIP1 to inhibit NF-κB activation.

Minocycline protects against myocardial ischemia/reperfusion injury in rats by upregulating MCPIP1 to inhibit NF-κB activation.

Journal: Acta pharmacologica Sinica

Published: November 05, 2018

Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.

Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.

Journal: Cardiovascular drugs and therapy

Published: February 13, 2018

Prosapogenin A inhibits cell growth of MCF7 via downregulating STAT3 and glycometabolism-related gene

Prosapogenin A inhibits cell growth of MCF7 via downregulating STAT3 and glycometabolism-related gene

Journal: Yao xue xue bao = Acta pharmaceutica Sinica

Published: December 24, 2013

Endogenous cystathionine-gamma-lyase/hydrogen sulfide pathway regulates apoptosis of HepG2 cells.

Endogenous cystathionine-gamma-lyase/hydrogen sulfide pathway regulates apoptosis of HepG2 cells.

Journal: Yao xue xue bao = Acta pharmaceutica Sinica

Published: November 06, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026